483 Aurobindo Pharma Mar 2019

483 Aurobindo Pharma Mar 2019

Walden Lee FDA, Jose Melendez FDA, Linda Murphy FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma - Mahabubnagar District, India facility and issued inspectional observations (via FDA 483) on 01 Mar 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Mar 2019
  • Location: Mahabubnagar District, India
  • FEI: 3011905047
Add To Cart